Tenofovir cuts HIV infection risk in injection drug users

06/13/2013 | HealthDay News

Researchers tracked more than 2,400 injection drug users in Thailand and found that daily intake of the antiviral drug tenofovir was associated with an almost 49% lower risk of HIV infection. Patients who most closely adhered to the prescribed regimen benefited the most from tenofovir's protective effect. The findings were reported in The Lancet.

View Full Article in:

HealthDay News

Published in Brief:

SmartBrief Job Listings for Health Care

Job Title Company Location
Senior Director, Biostatistics
Edwards Lifesciences
Irvine, CA
Diagnostic Technician
Roche
Marlborough, MA
Test Technician
Roche
Marlborough, MA
Associate - Food and Drug
Keller and Heckman LLP
Washington, DC
Senior Paralegal - Research & Development, and Medical
Boehringer Ingelheim
Ridgefield, CT